Skip to main content
Premium Trial:

Request an Annual Quote

Gentag, MacroArray to Collaborate on Wireless Prostate Cancer Assay

NEW YORK (GenomeWeb News) – Privately held firms Gentag and MacroArray Technologies said today that they will collaborate on developing a wireless immunoassay for prostate cancer.
 
The new test would combine Gentag’s cell-phone sensor technology with MacroArray’s proteomics discovery technology to create a disposable, wireless diagnostic test.
 
Gentag said the test would work similarly to currently available pregnancy strip tests, with men placing a urine sample on a test strip that incorporates an imbedded wireless tag. Antibodies on the strip would react with the sample and resulting data would be sent to an attending physician.
 
The firms plan to develop additional diagnostic tests based on their combined technologies, but the prostate cancer test is first in the pipeline.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.